• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2023 Fiscal Year Final Research Report

Anti-tumor Effect of Nicotinic Acid Activation on Canine Mastocytoma through GPER and Immunological Analysis of Tumor Microenvironment

Research Project

  • PDF
Project/Area Number 21K05927
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 42020:Veterinary medical science-related
Research InstitutionAzabu University

Principal Investigator

Okamoto Mariko  麻布大学, 獣医学部, 講師 (30415111)

Project Period (FY) 2021-04-01 – 2024-03-31
Keywordsイヌ肥満細胞腫 / KIT非依存性 / 肥満細胞腫マウスモデル / ナイアシン / ニコチン酸 / ニコチンアミド / GPER / 抗腫瘍作用
Outline of Final Research Achievements

In the treatment of cancer in dogs, especially in elderly dogs, drug administration is often necessary, considering the burden of surgical procedures. Therefore, there is a demand for therapeutic agents with low drug resistance and fewer side effects. In previous studies conducted by us, it was found that the administration of niacin induced cell death in canine mastocytoma cells. Although the antitumor effects of niacin have been previously reported, only the receptor GP109A has been highlighted as mediating its action. This study aimed to uncover a new aspect of the antitumor mechanism of niacin by investigating the involvement of not only GPR109A but also GPER.

Free Research Field

獣医学

Academic Significance and Societal Importance of the Research Achievements

報告者はこれまでに膜型エストロゲン受容体GPERの選択的アゴニストがマウスやイヌの肥満細胞腫細胞に細胞死を誘導することを見出した.さらにナイアシン(ニコチン酸,ニコチンアミド)がGPERを介して細胞内にシグナルを伝えることが報告されたため,ナイアシンによる抗腫瘍効果について検討したところ,ナイアシンが肥満細胞腫細胞の細胞死を誘導することを見出した.さらにマウス肥満細胞腫モデル系においてナイアシンの投与は腫瘍の増大を抑制しリンパ球の浸潤を促進することが示唆された.GPERの選択的アゴニストに比べナイアシンはコストが低く,さらに詳細な解析・検討を行うことであらたな治療法への提案に繋がると期待される

URL: 

Published: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi